Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at:

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at:

• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at:

Contact Info:
Name: Shirish Gupta
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 314328

Latest News

Zuckerberg asked to testify in UK; data firm's CEO suspended

Mar 20, 2018

LONDON — A British parliamentary committee on Tuesday summoned Facebook CEO Mark Zuckerberg to answer questions as authorities stepped up efforts to determine if the personal data of social-media users has been used improperly to influence elections. The request comes amid allegations that a data-mining firm based in the U.K. used information from more than 50 million Facebook accounts to help Donald Trump win the 2016 presidential election. The company, Cambridge Analytica, has denied wrongdoing. However, the firm's board of directions announced Tuesday evening that it had suspended CEO Alexander Nix pending an independent investigation of his actions. Nix made...

The Latest: Cambridge Analytica suspends CEO pending probe

Mar 20, 2018

LONDON — The Latest on the alleged use of personal Facebook data by political consulting firm Cambridge Analytica (all times local): 7:05 p.m. The board of Cambridge Analytica says it has suspended CEO Alexander Nix pending a full independent investigation of his actions. The board cited comments Nix made to an undercover reporter for Britain's Channel 4 News and other allegations of wrongdoing for its action Tuesday. It said his comments "do not represent the values or operations of the firm and his suspension reflects the seriousness with which we view the violation." The board said in an announcement posted...

Spring-themed cake for Prince Harry, Meghan's spring wedding

Mar 20, 2018

LONDON — Lemon, elderflower, fresh flower decorations: The cake for Prince Harry and Meghan Markle's May wedding will be appropriately spring-themed. Kensington Palace said Tuesday the royal wedding cake will be a lemon elderflower concoction incorporating "the bright flavors of spring." It'll be covered with buttercream, and adorned with fresh flowers. Look for a hint of California too — the designated pastry chef Claire Ptak was raised in California and worked as a pastry chef under the celebrated Alice Waters at Chez Panisse in Berkeley. Ptak now runs Violet Bakery in London. The palace says the couple are "very much...

Eddie Redmayne announces birth of second child, a boy

Mar 20, 2018

LONDON — Oscar winner Eddie Redmayne and his wife have announced the birth of their second child, a boy. Luke Richard Bagshawe Redmayne was born March 10. He joins his 21-month-old sister Iris Mary. The 36-year-old in February told ABC's "Live with Kelly and Ryan" that he and his wife, Hannah, did not know the sex of their babies before birth. Redmayne won an Oscar for portraying Stephen Hawking in the 2014 film "The Theory of Everything." He also appeared in the 2016 Harry Potter prequel "Fantastic Beasts and Where to Find Them."

At least 13 hurt after car rams into nightclub in Britain

Mar 20, 2018

LONDON — British police say a man who had been kicked out of a nightclub rammed his car into revelers on a dance floor, injuring at least 13 people. The Kent Police force says the 21-year-old has been arrested on suspicion of attempted murder over Saturday's crash in Gravesend, 30 miles (48 kilometers) southeast of London. Police say they are not treating the incident as terrorism. Footage posted on social media showed a large car on a dance floor inside a marquee tent at Blake's nightclub. On Facebook, the club thanked "the heroic actions of our door team and guests...

Sign up now!